Literature DB >> 27638745

Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.

Felix Nensa1, Julia Kloth2, Ercan Tezgah2, Thorsten D Poeppel3, Philipp Heusch4, Juliane Goebel5, Kai Nassenstein5, Thomas Schlosser5.   

Abstract

OBJECTIVE: Besides cardiac sarcoidosis, FDG-PET is rarely used in the diagnosis of myocardial inflammation, while cardiac MRI (CMR) is the actual imaging reference for the workup of myocarditis. Using integrated PET/MRI in patients with suspected myocarditis, we prospectively compared FDG-PET to CMR and the feasibility of integrated FDG-PET/MRI in myocarditis.
METHODS: A total of 65 consecutive patients with suspected myocarditis were prospectively assessed using integrated cardiac FDG-PET/MRI. Studies comprised T2-weighted imaging, late gadolinium enhancement (LGE), and simultaneous PET acquisition. Physiological glucose uptake in the myocardium was suppressed using dietary preparation.
RESULTS: FDG-PET/MRI was successful in 55 of 65 enrolled patients: two patients were excluded due to claustrophobia and eight patients due to failed inhibition of myocardial glucose uptake. Compared with CMR (LGE and/or T2), sensitivity and specificity of PET was 74% and 97%. Overall spatial agreement between PET and CMR was κ = 0.73. Spatial agreement between PET and T2 (κ = 0.75) was higher than agreement between PET and LGE (κ = 0.64) as well as between LGE and T2 (κ = 0.56).
CONCLUSION: In patients with suspected myocarditis, FDG-PET is in good agreement with CMR findings.

Entities:  

Keywords:  Fluorodeoxyglucose (FDG); PET imaging; PET/MR imaging; cardiovascular magnetic; myocarditis; resonance imaging

Mesh:

Substances:

Year:  2016        PMID: 27638745     DOI: 10.1007/s12350-016-0616-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  32 in total

Review 1.  Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders.

Authors:  Athar Haroon; Alimuddin Zumla; Jamshed Bomanji
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

2.  Diagnosis and treatment response evaluation of cardiac sarcoidosis using positron emission tomography/magnetic resonance imaging.

Authors:  Felix Nensa; Ercan Tezgah; Thorsten Poeppel; Kai Nassenstein; Thomas Schlosser
Journal:  Eur Heart J       Date:  2014-12-10       Impact factor: 29.983

3.  Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.

Authors:  Heiko Mahrholdt; Anja Wagner; Claudia C Deluigi; Eva Kispert; Stefan Hager; Gabriel Meinhardt; Holger Vogelsberg; Peter Fritz; Juergen Dippon; C-Thomas Bock; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

4.  Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging.

Authors:  Felix Nensa; Thorsten D Poeppel; Peter Krings; Thomas Schlosser
Journal:  Eur Heart J       Date:  2014-02-26       Impact factor: 29.983

5.  Confirmation of diagnosis and graduation of inflammatory activity of Loeffler endocarditis by hybrid positron emission tomography/magnetic resonance imaging.

Authors:  Nicolas Langwieser; Gesa von Olshausen; Christoph Rischpler; Tareq Ibrahim
Journal:  Eur Heart J       Date:  2014-04-08       Impact factor: 29.983

Review 6.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

7.  Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

Authors:  Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler
Journal:  J Nucl Med       Date:  2011-11-11       Impact factor: 10.057

8.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

9.  Active myocarditis in a patient with chronic active Epstein-Barr virus infection.

Authors:  Hiroyuki Takano; Keiichi Nakagawa; Naoki Ishio; Michiko Daimon; Masao Daimon; Yoshio Kobayashi; Kenzo Hiroshima; Issei Komuro
Journal:  Int J Cardiol       Date:  2007-10-25       Impact factor: 4.164

Review 10.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21
View more
  39 in total

1.  Assessment of myocardial viability of a patient with old myocardial infarction by 18F-fluorodeoxyglucose PET/MRI.

Authors:  Atsuro Masuda; Ayaka Nemoto; Takayoshi Yamaki; Noboru Oriuchi; Seiichi Takenoshita; Yasuchika Takeishi
Journal:  J Nucl Cardiol       Date:  2017-06-05       Impact factor: 5.952

2.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

Review 3.  Applications of PET-MR Imaging in Cardiovascular Disorders.

Authors:  Rhanderson Cardoso; Thorsten M Leucker
Journal:  PET Clin       Date:  2020-07-21

4.  Technical aspects of cardiac PET/MRI.

Authors:  Atsuro Masuda; Ayaka Nemoto; Yasuchika Takeishi
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

Review 5.  Positron emission tomography/MRI for cardiac diseases assessment.

Authors:  Osamu Manabe; Noriko Oyama-Manabe; Nagara Tamaki
Journal:  Br J Radiol       Date:  2020-02-14       Impact factor: 3.039

Review 6.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

Review 7.  Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease.

Authors:  Jayakumar Sreenivasan; Urvashi Hooda; Pragya Ranjan; Diwakar Jain
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

Review 8.  Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?

Authors:  Wengen Chen; Jean Jeudy
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

Review 9.  Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease.

Authors:  Min-Sun Kim; Eun-Kyung Kim; Joon Young Choi; Jae K Oh; Sung-A Chang
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

10.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.